Moderna Inc
USUSDModerna Inc (XETRA:0QF) — Biotechnology: Biological Products (No Diagnostic Substances). Número de bolsas en las que cotizan las acciones de la empresa: 3. En esta página: cotización y gráfico, dividendos, principales accionistas e historial del número de acciones.
Sobre la Empresa
- Sitio Web
- modernatx.com
- Relaciones con los Inversores
- investors.modernatx.com/
- Sector
- Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
- Sede Central
- Cambridge, United States
- Gestión
- Stéphane Bancel
- Empleados
- 5 800
- Fundada
- 2010
- IPO
- 2018-12-07
- Acciones en Circulación
- 399.24 M a 2026-07-24
- Capital Flotante
- 372.19 M
- Capitalización Bursátil
- 85.5 mil M USD
- Insiders
- 7.34%
- Inversores Institucionales
- 80.46%
- Industria (SIC)
- Biological Products, (No Diagnostic Substances)
- Forma Jurídica
- XTIQ
- ISIN
- US60770K1079
- LEI
- 549300EI6OKH5K5Q2G38
- P/B
- 12.6
- FCF
- −1.24 mil M USD
- Deuda
- 591 M USDcaja neta
- Resultados y FCF — para los 12 meses hasta 30.06.2026 (el último informe de la empresa).
- Beneficio Neto
- NAV
Descripción
Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company's respiratory vaccines include spikevax, mNEXSPIKE, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epstein-barr virus, and human immunodeficiency virus vaccines; enteric viruses include norovirus; public health vaccines consist of Zika, Nipah, and Mpox vaccines; and bacterial diseases vaccines, such as lyme vaccines. It also provides oncology therapeutics, such as intismeran autogene, cancer antigen therapy, t-cell engager, and cell therapy enhancer; and rare disease products, including propionic and methylmalonic acidemia, and cystic fibrosis. It has strategic alliances and collaborations with Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; immatics N.V.; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; The Bill & Melinda Gates Foundation; and OpenAI. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
Bolsas y Tickers
| Bolsa | Ticker | Moneda | Precio | Tipo |
|---|---|---|---|---|
| acciones ordinarias | ||||
| US USA Stocks | MRNA principal | USD | 222.76 +4.01% | acciones ordinarias |
| LSE London Stock Exchange | 0A45 IOB | USD | 196.5 +0.00% | acciones ordinarias |
| XETRA Xetra | 0QF secundaria | EUR | — | acciones ordinarias |
| certificado de depósito | ||||
| SA B3 Sao Paulo | M1RN34 | BRL | 50.55 +2.83% | certificado de depósito |
Principales Accionistas
| Titular | Participación | Acciones | Fecha del Informe |
|---|---|---|---|
| FMR, LLC | 12.99% | 51.86 M | 2026-06-30 |
| Blackrock Inc. | 7.66% | 30.6 M | 2026-06-30 |
| Vanguard Capital Managem… | 5.81% | 23.21 M | 2026-06-30 |
| Capital World Investors | 5.58% | 22.28 M | 2026-06-30 |
| Stéphane Bancel (Chief E… | ≈5.56% | 22.22 M | 2026-08-06 |
| BAILLIE GIFFORD & CO | 4.56% | 18.21 M | 2026-06-30 |
| State Street Corporation | 3.94% | 15.73 M | 2026-06-30 |
| Vanguard Portfolio Manag… | 3.9% | 15.58 M | 2026-06-30 |
| Growth Fund of America | 3.75% | 14.98 M | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 2.84% | 11.33 M | 2026-06-30 |
| Geode Capital Management… | 2.43% | 9.71 M | 2026-06-30 |
| Morgan Stanley | 2.39% | 9.54 M | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 2.29% | 9.15 M | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 2.05% | 8.19 M | 2026-06-30 |
| Theleme Partners LLP | 2.02% | 8.06 M | 2026-06-30 |
| Fidelity Mt. Vernon Stre… | 1.7% | 6.79 M | 2026-07-31 |
| Fidelity Securities Fund… | 1.33% | 5.31 M | 2026-07-31 |
| VANGUARD INDEX FUNDS-Van… | 1.3% | 5.19 M | 2026-06-30 |
| iShares Trust-iShares Co… | 1.18% | 4.7 M | 2026-08-31 |
| AMERICAN FUNDS INSURANCE… | 1.16% | 4.62 M | 2026-06-30 |
| VANGUARD WORLD FUND-Vang… | 1.15% | 4.58 M | 2026-05-31 |
| HOGE STEPHEN (President) | ≈0.43% | 1.72 M | 2026-09-15 |
| KLINGER SHANNON THYME (O… | ≈0.02% | 81 340 | 2026-09-04 |
| MOCK JAMES M (Chief Fina… | ≈0.01% | 59 375 | 2026-09-10 |
| NADER FRANCOIS E. (Direc… | ≈0.01% | 32 781 | 2026-04-30 |
| NABEL ELIZABETH G (Direc… | ≈0% | 19 317 | 2026-04-30 |
| HORNING SANDRA (Director… | ≈0% | 18 585 | 2026-04-30 |
| HUSSAIN SHAH ABBAS (Dire… | ≈0% | 12 066 | 2026-05-01 |
| Robert S. Langer, Jr. | — | — | — |
| Noubar Afeyan (Director) | — | — | 2026-05-21 |
| SAGAN PAUL L (Director) | — | — | 2025-03-03 |
Inicia Sesión con Google